Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Reyataz 100mg capsules
0503010L0BBACAC
|
Reyataz | Atazanavir | Infections | No data available |
|
Reyataz 150mg capsules
0503010L0BBAAAA
|
Reyataz | Atazanavir | Infections | No data available |
|
Reyataz 200mg capsules
0503010L0BBABAB
|
Reyataz | Atazanavir | Infections | No data available |
|
Reyataz 300mg capsules
0503010L0BBADAD
|
Reyataz | Atazanavir | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.